Published in Shock on July 01, 2000
Pancreatic trypsin increases matrix metalloproteinase-9 accumulation and activation during acute intestinal ischemia-reperfusion in the rat. Am J Pathol (2004) 1.33
Impaired small-bowel barrier integrity in the presence of lumenal pancreatic digestive enzymes leads to circulatory shock. Shock (2012) 0.99
Pancreatic duct ligation reduces lung injury following trauma and hemorrhagic shock. Ann Surg (2004) 0.97
Clinical review: splanchnic ischaemia. Crit Care (2002) 0.95
2008 Landis Award lecture. Inflammation and the autodigestion hypothesis. Microcirculation (2009) 0.91
Autodigestion: Proteolytic Degradation and Multiple Organ Failure in Shock. Shock (2016) 0.85
In vivo analysis of intestinal permeability following hemorrhagic shock. World J Crit Care Med (2015) 0.78
A journey with Tony Hugli up the inflammatory cascade towards the auto-digestion hypothesis. Int Immunopharmacol (2007) 0.78
The autodigestion hypothesis for shock and multi-organ failure. Ann Biomed Eng (2013) 0.78
The autodigestion hypothesis: Proteolytic receptor cleavage in rheological and cardiovascular cell dysfunction1. Biorheology (2016) 0.75
Heart period and blood pressure characteristics in splanchnic arterial occlusion shock-induced collapse. J Clin Monit Comput (2015) 0.75
Enteral tranexamic acid attenuates vasopressor resistance and changes in α1-adrenergic receptor expression in hemorrhagic shock. J Trauma Acute Care Surg (2017) 0.75
Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions. J Immunol (1978) 6.04
Passive mechanical properties of human leukocytes. Biophys J (1981) 3.63
Anaphylatoxins: C3a and C5a. Adv Immunol (1978) 3.44
Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A (1978) 3.08
Morphometry of human leukocytes. Blood (1980) 3.07
Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. Am J Pathol (1991) 2.92
Partial characterization of human C5a anaphylatoxin. I. Chemical description of the carbohydrate and polypeptide prtions of human C5a. J Immunol (1976) 2.90
Determination of the tryptophan content of proteins by ion exchange chromatography of alkaline hydrolysates. J Biol Chem (1972) 2.72
Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med (1981) 2.63
Release of histamine from rat mast cells by the complement peptides C3a and C5a. Immunology (1975) 2.62
The alternative pathway C3/C5 convertase: chemical basis of factor B activation. J Immunol (1979) 2.58
The interaction of leukocytes and erythrocytes in capillary and postcapillary vessels. Microvasc Res (1980) 2.49
Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol (1983) 2.37
Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a. J Biol Chem (1978) 2.32
Leukocyte relaxation properties. Biophys J (1988) 2.27
Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke (1991) 2.10
Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion. Circulation (1995) 2.08
Human anaphylatoxin (C3a) from the third component of complement. Primary structure. J Biol Chem (1975) 2.08
Structure and function of the anaphylatoxins. Springer Semin Immunopathol (1984) 2.07
Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastroenterology (1994) 2.07
Passive deformation analysis of human leukocytes. J Biomech Eng (1988) 2.03
Nucleotide sequence of cDNA and derived amino acid sequence of human complement component C9. Proc Natl Acad Sci U S A (1984) 2.01
Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Am J Physiol (1986) 1.99
Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci U S A (1995) 1.98
Activation of complement components C3 and C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (Bacteroides) gingivalis. J Biol Chem (1992) 1.96
Cell distribution in capillary networks. Microvasc Res (1980) 1.91
Purification and partial characterization of human and porcine C3a anaphylatoxin. J Biol Chem (1975) 1.82
Influence of physicochemical factors on rheology of human neutrophils. Biophys J (1982) 1.80
In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest (1993) 1.80
Requirement and role of C5a in acute lung inflammatory injury in rats. J Clin Invest (1996) 1.77
Isolation of three separate anaphylatoxins from complement-activated human serum. Mol Cell Biochem (1981) 1.70
Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res (1993) 1.63
Prostacyclin: a potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia. Science (1978) 1.62
Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment. J Immunol (2000) 1.57
Atrial-like phenotype is associated with embryonic ventricular failure in retinoid X receptor alpha -/- mice. Proc Natl Acad Sci U S A (1995) 1.56
Thromboxane release during pacing-induced angina pectoris: possible vasoconstrictor influence on the coronary vasculature. Circulation (1980) 1.56
Capillary plugging by granulocytes and the no-reflow phenomenon in the microcirculation. Fed Proc (1987) 1.56
A modified method for chemotaxis under agarose. J Immunol Methods (1979) 1.55
The leukocyte response to fluid stress. Proc Natl Acad Sci U S A (1997) 1.53
Activated neutrophils aggravate endothelial dysfunction after reperfusion of the ischemic feline myocardium. Am Heart J (1992) 1.53
Heat-induced fragmentation of human alpha 2-macroglobulin. J Biol Chem (1979) 1.53
Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2. Proc Natl Acad Sci U S A (1980) 1.52
The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a. Crit Rev Immunol (1981) 1.51
Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity. Hypertension (2000) 1.50
Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. J Hypertens (1998) 1.48
Role of cell surface contact in the kinetics of superoxide production by granulocytes. J Clin Invest (1983) 1.48
Pulmonary injury induced by C3a and C5a anaphylatoxins. Am J Pathol (1980) 1.48
Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion. J Clin Invest (1991) 1.48
Studies on the protective effect of prostacyclin in acute myocardial ischemia. Eur J Pharmacol (1979) 1.47
Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation. Proc Natl Acad Sci U S A (1979) 1.47
Viscoelastic properties of leukocytes. Kroc Found Ser (1984) 1.45
Endotoxin-induced shock in the rat. A role for C5a. Am J Pathol (1989) 1.44
Biophysical aspects of microsphere engulfment by human neutrophils. Biophys J (1988) 1.44
Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase. J Immunol (1983) 1.44
In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats. Hydroethidine microfluorography. Hypertension (1995) 1.43
Human C5a and C5a analogs as probes of the neutrophil C5a receptor. Mol Immunol (1980) 1.41
Regulation of immune response by components of the complement cascade and their activated fragments. Springer Semin Immunopathol (1983) 1.41
Protective action of methylprednisolone on the myocardium during experimental myocardial ischemia in the cat. Circ Res (1974) 1.40
Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation (1992) 1.40
Evidence for a second valve system in lymphatics: endothelial microvalves. FASEB J (2001) 1.40
Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats. Arterioscler Thromb Vasc Biol (1999) 1.39
Lipoxin A4 stable analogs inhibit leukocyte rolling and adherence in the rat mesenteric microvasculature: role of P-selectin. Proc Natl Acad Sci U S A (1997) 1.38
Beneficial effects of two forms of NO administration in feline splanchnic artery occlusion shock. Am J Physiol (1990) 1.37
Arachidonate metabolism by human polymorphonuclear leukocytes stimulated by N-formyl-Met-Leu-Phe or complement component C5a is independent of phospholipase activation. Proc Natl Acad Sci U S A (1983) 1.37
C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation. J Exp Med (1995) 1.36
Neutrophil chemotactic factors promote leukocytosis. A common mechanism for cellular recruitment from bone marrow. J Immunol (1992) 1.36
New morphological evidence for a mechanism of lymph formation in skeletal muscle. Microvasc Res (1984) 1.35
C4a: the third anaphylatoxin of the human complement system. Proc Natl Acad Sci U S A (1979) 1.34
Simvastatin exerts both anti-inflammatory and cardioprotective effects in apolipoprotein E-deficient mice. Circulation (2001) 1.34
Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit Care Med (1991) 1.33
Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation (1990) 1.31
Accumulation of polymorphonuclear leukocytes during 3-h experimental myocardial ischemia. Am J Physiol (1986) 1.30
Presence of a myocardial depressant factor in patients in circulatory shock. Surgery (1971) 1.28
Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin. Am J Pathol (1994) 1.28
The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation (1992) 1.28
Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion. J Pharmacol Exp Ther (1990) 1.26
Limited degradation of the third component (C3) of human complement by human leukocyte elastase (HLE): partial characterization of C3 fragments. Biochemistry (1977) 1.26
Structural changes accompanying enzymatic activation of human Hageman factor. J Clin Invest (1974) 1.25
Biochemistry and biology of anaphylatoxins. Complement (1986) 1.25
Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J Clin Invest (1997) 1.24
Cardiovascular effects of acute hypercholesterolemia in rabbits. Reversal with lovastatin treatment. J Clin Invest (1989) 1.24
Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulin. Am J Physiol Endocrinol Metab (2001) 1.23
Characterization of a C5a receptor on human polymorphonuclear leukocytes (PMN). J Immunol (1985) 1.23
Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a. Proc Natl Acad Sci U S A (1981) 1.23
Suppression of T lymphocyte functions by human C3 fragments. I. Inhibition of human T cell proliferative responses by a kallikrein cleavage fragment of human iC3b. J Immunol (1983) 1.22
Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J Pharmacol Exp Ther (1992) 1.22
Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion. Am J Physiol (1994) 1.21
Anti-C5a receptor antibodies. Characterization of neutralizing antibodies specific for a peptide, C5aR-(9-29), derived from the predicted amino-terminal sequence of the human C5a receptor. J Immunol (1993) 1.21
Radioimmunoassay for anaphylatoxins: a sensitive method for determining complement activation products in biological fluids. Anal Biochem (1984) 1.21
Lack of endothelium-dependent relaxation in coronary resistance arteries of cholesterol-fed rabbits. Am J Physiol (1989) 1.21
Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release. J Clin Invest (1979) 1.20
Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc Natl Acad Sci U S A (1998) 1.19
C5a-induced hemodynamic and hematologic changes in the rabbit. Role of cyclooxygenase products and polymorphonuclear leukocytes. Am J Pathol (1987) 1.18
Blood-borne humoral factors in the pathophysiology of circulatory shock. Circ Res (1973) 1.18
Anaphylatoxin from the fifth component of porcine complement. Purification and partial chemical characterization. J Biol Chem (1979) 1.17
C5a-mediated release of interleukin 6 by human monocytes. Clin Immunol Immunopathol (1990) 1.16
Time course of coronary vascular endothelial adhesion molecule expression during reperfusion of the ischemic feline myocardium. J Leukoc Biol (1995) 1.16
Synthetic peptides with the biological activities and specificity of human C3a anaphylatoxin. Proc Natl Acad Sci U S A (1977) 1.16
Leukocyte-endothelium interaction during the early stages of hypercholesterolemia in the rabbit: role of P-selectin, ICAM-1, and VCAM-1. Arterioscler Thromb Vasc Biol (1998) 1.15